Chloroquine

Generic Name
Chloroquine
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C18H26ClN3
CAS Number
54-05-7
Unique Ingredient Identifier
886U3H6UFF
Background

Chloroquine is an aminoquinolone derivative first developed in the 1940s for the treatment of malaria. It was the drug of choice to treat malaria until the development of newer antimalarials such as pyrimethamine, artemisinin, and mefloquine. Chloroquine and its derivative hydroxychloroquine have since been repurposed for the treatment of a number of other c...

Indication

Chloroquine is indicated to treat infections of P. vivax, P. malariae, P. ovale, and susceptible strains of P. falciparum. It is also used to treat extraintestinal amebiasis.
...

Associated Conditions
Discoid Lupus Erythematosus (DLE), Extraintestinal Amebiasis, Malaria, Polymorphic Light Eruption (PLE), Porphyria Cutanea Tarda, Rheumatoid Arthritis, Sarcoidosis, Acute, uncomplicated Malaria
Associated Therapies
-

A Phase 2 Randomized, Double-blind Trial Evaluating the Effects of Chloroquine in Breast Cancer

First Posted Date
2015-01-07
Last Posted Date
2016-11-18
Lead Sponsor
Ottawa Hospital Research Institute
Target Recruit Count
60
Registration Number
NCT02333890
Locations
🇨🇦

The Ottawa Hospital Woman's Breast Health Centre, Ottawa, Ontario, Canada

Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria

First Posted Date
2014-08-13
Last Posted Date
2018-05-16
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
251
Registration Number
NCT02216123
Locations
🇻🇳

GSK Investigational Site, Ho Chi Minh, Vietnam

Comparison of the ECG Effects Related to Pharmacokinetic Profile of Chloroquine and Piperaquine

First Posted Date
2014-07-17
Last Posted Date
2015-11-03
Lead Sponsor
University of Oxford
Target Recruit Count
16
Registration Number
NCT02192944
Locations
🇹🇭

Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

Effect of Liver and Blood-stage Treatment on Subsequent Plasmodium Reinfection and Morbidity

First Posted Date
2014-05-21
Last Posted Date
2014-05-21
Lead Sponsor
Papua New Guinea Institute of Medical Research
Target Recruit Count
524
Registration Number
NCT02143934
Locations
🇵🇬

PNG Institute of Medical Research, Maprik, East Sepik Province, Papua New Guinea

Target Antigens Induced by Plasmodium Falciparum Sporozoite Immunization Under Chemoprophylaxis

First Posted Date
2014-03-06
Last Posted Date
2015-08-10
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
15
Registration Number
NCT02080026
Locations
🇳🇱

Radboud university medical center, Nijmegen, Gelderland, Netherlands

Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors

First Posted Date
2014-02-26
Last Posted Date
2019-11-25
Lead Sponsor
University of Cincinnati
Target Recruit Count
24
Registration Number
NCT02071537
Locations
🇺🇸

University of Cincinnati Cancer Institute, Cincinnati, Ohio, United States

"Pharmacoepidemiological Evaluation of Autophagy Inhibition in Treatment of HCV Patients Resistant to Standard Therapy. Pilot Study"

First Posted Date
2014-02-07
Last Posted Date
2015-10-20
Lead Sponsor
Shiraz University of Medical Sciences
Target Recruit Count
10
Registration Number
NCT02058173
Locations
🇮🇷

Health Policy Research Center, Shiraz, Fars, Iran, Islamic Republic of

Plasmodium Vivax Efficacy Trial in Cruzeiro do Sul, Acre, Brazil

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2014-01-23
Last Posted Date
2018-02-07
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
119
Registration Number
NCT02043652
Locations
🇧🇷

Hospital do Jurua, Cruzeiro do Sul, Brazil

Chloroquine as a Modulator of T Cell Immune Activation

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2013-12-09
Last Posted Date
2013-12-09
Lead Sponsor
CIHR Canadian HIV Trials Network
Target Recruit Count
19
Registration Number
NCT02004314
Locations
🇨🇦

Montreal Chest Institute, McGill University Health Centre, Montreal, Quebec, Canada

P. Knowlesi Trial of Artemether-lumefantrine vs Chloroquine

First Posted Date
2013-12-04
Last Posted Date
2017-07-07
Lead Sponsor
Menzies School of Health Research
Target Recruit Count
123
Registration Number
NCT02001012
Locations
🇲🇾

Pitas District Hospital, Pitas, Sabah, Malaysia

🇲🇾

Kota Marudu District Hospital, Kota Marudu, Sabah, Malaysia

🇲🇾

Kudat District Hospital, Kudat, Sabah, Malaysia

© Copyright 2024. All Rights Reserved by MedPath